Homozygosity for the R1268Q mutation in MRP6, the pseudoxanthoma elasticum gene, is not disease-causing

被引:36
作者
Germain, DP [1 ]
Perdu, J [1 ]
Remones, V [1 ]
Jeunemaitre, X [1 ]
机构
[1] Univ Paris 06, Hop Europeen Georges Pompidou, Dept Genet, Paris, France
关键词
MRP6; multidrug resistance protein 6; ATP binding cassette transporters; pseudoxanthoma elasticum;
D O I
10.1006/bbrc.2000.3101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pseudoxanthoma elasticum (PXE) is an inherited systemic disorder of connective tissue, characterized by progressive calcification of the elastic fibers in the eye, the skin, and the cardiovascular system, resulting in decreased vision, skin lesions, and life-threatening vascular disease, with highly variable phenotypic expression. The PXE locus has been mapped to chromosome 16p13.1, and was recently further refined to a 500 kb-region, containing two pseudogenes and four candidate genes. In a comprehensive mutational screening, we were able to exclude the responsibility of pM5, UNK, and MRP1 genes, candidate on the basis of their genetic localization, Conversely, we have found pathogenetic mutations in the MRP6 gene, in patients affected with PXE, indicating that human MRP6, which encodes a 1503 amino-acids membrane protein, member of the human ATP binding cassette (ABC) transporters superfamily, is the gene responsible for PXE. In one large PXE pedigree for which we had identified a nonsense mutation (R1141X), we came across a G to A transition at position 3803 of the MRP6 cDNA sequence (R1268Q). Astonishingly, this latter variant was found at the homozygous state in the proband's unaffected husband. We investigated the R1268Q mutation, and found the Q1268 allele at a relatively high frequency (0.19) in a Caucasian control population (n = 62 subjects). Genotype frequencies were in Hardyn-Teinberg equilibrium, and three healthy volunteers were homozygous for the Q1268 allele. These data indicate that the R1268Q variant in the MRP6 gene does not cause PXE per se. Further studies will, elucidate if it may play a role when found in compound heterozygotes. (C) 2000 Academic Press.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 20 条
  • [1] A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus:: high-resolution mapping and genomic structure
    Cai, L
    Struk, B
    Adams, MD
    Ji, W
    Haaf, T
    Kang, HL
    Dho, SH
    Xu, XQ
    Ringpfeil, F
    Nancarrow, J
    Zäch, S
    Schaen, L
    Stumm, M
    Niu, TH
    Chung, J
    Lunze, K
    Verrecchia, B
    Goldsmith, LA
    Viljoen, D
    Figuera, LE
    Fuchs, W
    Lebwohl, M
    Uitto, J
    Richards, R
    Hohl, D
    Ramesar, R
    Callen, DF
    Kim, UJ
    Doggett, NA
    Neldner, KH
    Lindpainter, K
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (01): : 36 - 46
  • [2] Cotton RGH, 2000, HUM MUTAT, V15, P16, DOI 10.1002/(SICI)1098-1004(200001)15:1<16::AID-HUMU6>3.0.CO
  • [3] 2-S
  • [4] Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO
  • [5] 2-M
  • [6] Exhaustive screening of the acid β-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers:: Mutation profile and genotype/phenotype correlations in Gaucher disease
    Germain, DP
    Puech, JP
    Caillaud, C
    Kahn, A
    Poenaru, L
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) : 415 - 427
  • [7] Analysis of the intron-exon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA
    Grant, CE
    Kurz, EU
    Cole, SPC
    Deeley, RG
    [J]. GENOMICS, 1997, 45 (02) : 368 - 378
  • [8] Hirohashi T, 1998, MOL PHARMACOL, V53, P1068
  • [9] STRUCTURAL MODEL OF ATP-BINDING PROTEINS ASSOCIATED WITH CYSTIC-FIBROSIS, MULTIDRUG RESISTANCE AND BACTERIAL TRANSPORT
    HYDE, SC
    EMSLEY, P
    HARTSHORN, MJ
    MIMMACK, MM
    GILEADI, U
    PEARCE, SR
    GALLAGHER, MP
    GILL, DR
    HUBBARD, RE
    HIGGINS, CF
    [J]. NATURE, 1990, 346 (6282) : 362 - 365
  • [10] MRP3, an organic anion transporter able to transport anti-cancer drugs
    Kool, M
    van der Linden, M
    de Haas, M
    Scheffer, GL
    de Vree, JML
    Smith, AJ
    Jansen, G
    Peters, GJ
    Ponne, N
    Scheper, RJ
    Elferink, RPJO
    Baas, F
    Borst, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6914 - 6919